Literature DB >> 22389029

An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.

Xiaowen Liu1, Weiqi Sheng, Yanong Wang.   

Abstract

OBJECTIVE: To investigate the differences between alpha-fetoprotein-producing gastric cancer (AFPPGC) and hepatoid adenocarcinoma of the stomach (HAS), and the clinicopathologic features and prognosis of HAS.
METHODS: From 1996 to 2007, there were 111 patients with elevated serum level of alpha-fetoprotein (AFP) preoperatively in Fudan University Shanghai Cancer Center. Primary lesions of 104 patients were stained positively for AFP. Among these patients, 45 patients were diagnosed as HAS. The clinicopathologic characteristics and prognostic factors of AFPPGC and HAS were analyzed. Additionally, 208 stage-matched AFP-negative gastric cancer patients were selected as control.
RESULTS: Immunohistochemically, the tumor cells were positive for AFP in AFPPGC. Histologically, the polygonal tumor cells were arranged in trabecular fashion or solid nests separated by narrow fibrous stroma composed of sinusoid-like capillaries in HAS. The survival rates of the three groups were statistically different (P < 0.01).
CONCLUSION: AFP-producing gastric cancer and HAS had more aggressive behavior than that of common gastric cancer. The prognosis of HAS was poorer than that of AFPPGC, therefore it should be distinguished from the latter.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22389029     DOI: 10.1002/jso.23073

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  26 in total

1.  Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series.

Authors:  Xiang-Yu Zeng; Yu-Ping Yin; Hua Xiao; Peng Zhang; Jun He; Wei-Zhen Liu; Jin-Bo Gao; Xiao-Ming Shuai; Guo-Bin Wang; Xiu-Li Wu; Kai-Xiong Tao
Journal:  Curr Med Sci       Date:  2018-12-07

2.  Hepatoid adenocarcinoma of the stomach: A case report and review of the literature.

Authors:  R U Zhou; Yantao Cai; Y I Yang; Jianbin Xiang; Zongyou Chen
Journal:  Oncol Lett       Date:  2015-02-20       Impact factor: 2.967

3.  Alpha-fetoprotein can promote gastric cancer progression via upregulation of metastasis-associated colon cancer 1.

Authors:  Xiang Mao; Jun Wang; Fen Luo
Journal:  Oncol Lett       Date:  2022-01-18       Impact factor: 2.967

4.  Hepatoid adenocarcinoma of the stomach is a special and easily misdiagnosed or missed diagnosed subtype of gastric cancer with poor prognosis but curative for patients of pN0/1: the experience of a single center.

Authors:  Yibin Xie; Zhonghai Zhao; Peng Li; Yang Wang; Chunguang Guo; Xiaoliang Wang; Wei Tang; Qian Liu; Ning Lu; Liyan Xue; Dongbing Zhao
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 5.  Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.

Authors:  Hideaki Shimada; Tamaki Noie; Manabu Ohashi; Koji Oba; Yutaka Takahashi
Journal:  Gastric Cancer       Date:  2013-04-10       Impact factor: 7.370

6.  Salvage surgery after chemotherapy with S-1 plus cisplatin for α-fetoprotein-producing gastric cancer with a portal vein tumor thrombus: a case report.

Authors:  Shigetomi Nakao; Bunzo Nakata; Masashige Tendo; Kenji Kuroda; Takeshi Hori; Mayumi Inaba; Kosei Hirakawa; Tetsuro Ishikawa
Journal:  BMC Surg       Date:  2015-01-16       Impact factor: 2.102

Review 7.  PRISMA-Compliant Article: Clinical Characteristics and Factors Influencing Prognosis of Patients With Hepatoid Adenocarcinoma of the Stomach in China.

Authors:  Bao-Ge Qu; Wei-Min Bi; Bao-Teng Qu; Tao Qu; Xing-Hai Han; Hui Wang; Yuan-Xun Liu; Yi-Guo Jia
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

8.  Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.

Authors:  Jun Lu; Yongfeng Ding; Yanyan Chen; Junjie Jiang; Yiran Chen; Yingying Huang; Mengjie Wu; Chengzhi Li; Mei Kong; Wenyi Zhao; Haohao Wang; Jing Zhang; Zhongqi Li; Yimin Lu; Xiongfei Yu; Ketao Jin; Donghui Zhou; Tianhua Zhou; Fei Teng; Haibin Zhang; Zhan Zhou; Haiyong Wang; Lisong Teng
Journal:  Nat Commun       Date:  2021-06-24       Impact factor: 14.919

9.  Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.

Authors:  Yong Kang Lee; Seung Up Kim; Do Young Kim; Sang Hoon Ahn; Kwang Hun Lee; Do Yun Lee; Kwang-Hyub Han; Chae Yoon Chon; Jun Yong Park
Journal:  BMC Cancer       Date:  2013-01-03       Impact factor: 4.430

10.  Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.

Authors:  Hung-Hsin Lin; Chia-Chu Chang; Shung-Haur Yang; Shih-Ching Chang; Wei-Shone Chen; Wen-Yih Liang; Jen-Kou Lin; Jeng-Kai Jiang
Journal:  World J Surg Oncol       Date:  2016-03-15       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.